11 followers
We reported that relugolix, an oral gonadotrophin-releasing hormone receptor antagonist, for FIGO type 0 submucosal leiomyoma can cause severe bleeding in BMC. However, FIGO type 1 and 2 with relugorix did not develop hemorrhage. https://t.co/7UtrIxbZYD